Literature DB >> 30935846

Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices.

Shellie D Ellis1, Mugur Geana2, Christine B Mackay3, Deborah J Moon4, Jessie Gills5, Andrew Zganjar6, Gayle Brekke4, J Brantley Thrasher6, Tomas L Griebling7.   

Abstract

OBJECTIVE: Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities.
METHODS: We conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trials. Participants were asked to consider barriers and strategies that might support engaging their patients in discussions about urological cancer clinical trials and referring them appropriately. Recorded interviews were transcribed and coded using template analysis.
RESULTS: Most participants were not aware of available trials and had no experience with trial referral. Overall, participants held positive attitudes toward clinical trials and recognized their potential roles in accrual, but limited local resources reduced opportunities for offering trials. Most participants expressed a need for increased human, financial, and other resources to support this role. Many participants requested information and training to increase their knowledge of clinical trials and confidence in offering them to patients. Participants highlighted the need to build efficient pathways to identify available trials, match eligible patients, and facilitate communication and collaboration with cancer centers for patient follow-up and continuity of care.
CONCLUSIONS: With adequate logistical and informational support, community urology practices could play an important role in clinical trial accrual, advancing cancer research and increasing treatment options for rural cancer patients. Future studies should explore the effectiveness of strategies to optimize urology practices' role in clinical trial accrual.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer care delivery; Clinical trials; Community practice; Implementation science; Physician recommendation; Urological cancer

Year:  2019        PMID: 30935846      PMCID: PMC6661185          DOI: 10.1016/j.urolonc.2019.03.004

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  35 in total

1.  Making psychological theory useful for implementing evidence based practice: a consensus approach.

Authors:  S Michie; M Johnston; C Abraham; R Lawton; D Parker; A Walker
Journal:  Qual Saf Health Care       Date:  2005-02

2.  Urologists' attitudes regarding cancer clinical research.

Authors:  Gregory P Swanson; William R Carpenter; Ian M Thompson; E David Crawford
Journal:  Urology       Date:  2007-07       Impact factor: 2.649

Review 3.  Barriers to participation in randomised controlled trials: a systematic review.

Authors:  S Ross; A Grant; C Counsell; W Gillespie; I Russell; R Prescott
Journal:  J Clin Epidemiol       Date:  1999-12       Impact factor: 6.437

4.  Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial.

Authors:  Paul B Jacobsen; Kristen J Wells; Cathy D Meade; Gwendolyn P Quinn; Ji-Hyun Lee; William J Fulp; Jhanelle E Gray; Rachid C Baz; Gregory M Springett; Richard M Levine; Merry-Jennifer Markham; Fred J Schreiber; Thomas H Cartwright; James M Burke; Robert D Siegel; Mokenge P Malafa; Daniel Sullivan
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

5.  How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.

Authors:  Warren B Sateren; Edward L Trimble; Jeffrey Abrams; Otis Brawley; Nancy Breen; Leslie Ford; Mary McCabe; Richard Kaplan; Malcolm Smith; Richard Ungerleider; Michaele C Christian
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

6.  Public attitudes toward participation in cancer clinical trials.

Authors:  Robert L Comis; Jon D Miller; Carolyn R Aldigé; Linda Krebs; Ellen Stoval
Journal:  J Clin Oncol       Date:  2003-03-01       Impact factor: 44.544

7.  Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials.

Authors:  Claudia R Baquet; Gary L Ellison; Shiraz I Mishra
Journal:  J Clin Oncol       Date:  2008-07-10       Impact factor: 44.544

8.  Incremental treatment costs in national cancer institute-sponsored clinical trials.

Authors:  Dana P Goldman; Sandra H Berry; Mary S McCabe; Meredith L Kilgore; Arnold L Potosky; Michael L Schoenbaum; Matthias Schonlau; Jane C Weeks; Richard Kaplan; Jose J Escarce
Journal:  JAMA       Date:  2003-06-11       Impact factor: 56.272

9.  Drug costs and out-of-pocket spending in cancer clinical trials.

Authors:  Meredith L Kilgore; Dana P Goldman
Journal:  Contemp Clin Trials       Date:  2007-05-06       Impact factor: 2.226

10.  Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the Theoretical Domains Framework.

Authors:  Simon D French; Sally E Green; Denise A O'Connor; Joanne E McKenzie; Jill J Francis; Susan Michie; Rachelle Buchbinder; Peter Schattner; Neil Spike; Jeremy M Grimshaw
Journal:  Implement Sci       Date:  2012-04-24       Impact factor: 7.327

View more
  4 in total

1.  A Framework for Equitable Partnerships to Promote Cancer Prevention and Control in Rural Settings.

Authors:  Linda K Ko; Isabel C Scarinci; Elizabeth G Bouchard; Bettina F Drake; Elisa M Rodriguez; Moon S Chen; Deanna Kepka; Aaron J Kruse-Diehr; Christie Befort; Jackilen Shannon; Paige E Farris; Amy Trentham-Dietz; Tracy Onega
Journal:  JNCI Cancer Spectr       Date:  2022-03-02

Review 2.  Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices.

Authors:  Shellie Ellis; Mugur Geana; Tomas Griebling; Charles McWilliams; Jessie Gills; Kelly Stratton; Christine Mackay; Ariel Shifter; Andrew Zganjar; Brantley Thrasher
Journal:  Trials       Date:  2019-10-07       Impact factor: 2.279

3.  Access to urologists for participation in research: An analysis of NCI's Community Oncology Research Program landscape survey.

Authors:  Shellie D Ellis; Riha Vaidya; Joseph M Unger; Kelly Stratton; Jessie Gills; Peter Van Veldhuizen; Eileen Mederos; Emily V Dressler; Matthew F Hudson; Charles Kamen; Heather B Neuman; Anne E Kazak; Ruth C Carlos; Kathryn E Weaver
Journal:  Contemp Clin Trials Commun       Date:  2022-08-14

4.  Development of a co-designed behaviour change intervention aimed at healthcare professionals recruiting to clinical trials in maternity care.

Authors:  Linda Biesty; Katie Gillies; Vivienne Hanrahan; Louisa Lawrie; Eilidh Duncan
Journal:  Trials       Date:  2022-10-12       Impact factor: 2.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.